The Board advised all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to immediately cease further distribution

The Pharmacy and Poisons Board (PPB) has directed that all pharmaceutical outlets, healthcare facilities and healthcare professionals immediately halt the sale of three drugs circulating the Kenyan market.

In different statements issued on Thursday, April 24, PPB alerted members of the public regarding the detection of falsified Augmentin 1g (Batch SGS2) and Augmentin 625mg (Batch numbers 8X3K and EU7C) in the Kenyan market.

In view of the above, the Board advises all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to IMMEDIATELY CEASE further distribution, sale, issuing, or use of the outlined product batch and return the same to their nearest healthcare facility or respective suppliers," directed PPB.

Augmentin is an antibiotic used to treat a variety of bacterial infections. It combines two active ingredients: amoxicillin, which kills bacteria, and clavulanic acid, which helps amoxicillin work more effectively by stopping bacteria from resisting it.